Glen Sato Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Portfolio
  • 1

Glen Sato General Information

Description

Mr. Glen Sato serves as Board Member at Grove Biopharma. Mr. Sato served as a Partner at Cooley. He is also an Angel Investor. He is a partner in the Life Sciences and Public Securities practice groups and a member of Cooley Godward Kronish's Business department. He rejoined the Firm in 2006 and is a resident in the Palo Alto office. Mr. Sato's practice focuses on corporate transactions, SEC reporting and compliance, disclosure issues, intellectual property licensing and licensing strategy, general corporate counseling, insider trading compliance and working with Boards of Directors and audit committees on various risk and accounting-related matters. Together with strong finance capabilities, Sato also has substantial experience in corporate partnering, international and domestic M&A and other heavily negotiated transactions. He has worked closely with underwriters on public and private company acquisitions and led initial public, follow-on and secondary and convertible note offerings. He has also led or been significantly involved in corporate partnering and licensing transactions involving pharmaceutical and biotechnology companies such as Abbott, Bayer, Biogen Idec, Bristol-Myers Squibb, Exelixis, Eli Lilly, Genentech, GlaxoSmithKline, MedImmune, PDL BioPharma, Progenics, Roche, Sankyo and Tanox. Prior to joining the Firm, Mr. Sato served in diverse legal, financial, operational, and strategic planning positions where his responsibilities included finance, business development, IT, HR and Facilities. He most recently served as Protein Design Labs' (PDL) Senior Vice President and Chief Financial Officer. He joined PDL from Exelixis, where he served as SVP, Chief Financial Officer and General Counsel for approximately three years. Prior to his time at Exelixis, he served in various legal and strategic planning positions at PDL, including Vice President, Legal and General Counsel. In addition, Mr. Sato worked at NeXT Computer as Associate General Counsel. He was an attorney in Cooley Godward Kronish's Business Department in Palo Alto for two years. Mr. Sato started his career at Jones, Day in Washington, DC. Mr. Sato received his JD and MBA from UCLA in 1987, where he was an Associate Editor of the Law Review. He received a Bachelor's degree in Economics and the College of Social Studies in 1981 from Wesleyan University. Mr. Sato is a member of the State Bar of California and an inactive member of the Washington, DC Bar Association.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 1375 West Fulton Street
  • Suite 650
  • Chicago, IL 60607
  • United States
+1 (650) 000-0000

Glen Sato Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000 26-Jun-2019 00000 00000 000 Business/Productivity Software Generating Revenue 0000 0000 00

Glen Sato Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Glen Sato Team (1)

Name Title Deals Funds Boards Office
Glen Sato JD Angel Investor 0 0 Chicago, IL

Glen Sato Co-Investors (17)

Name With Exits Lead Partner Series Industry
Jeff Suto 1 0 Series chart Industry bar
Merus Capital 0 0 Series chart Industry bar
Rationalwave Capital Partners 0 0 Series chart Industry bar
Stanford Health Care 0 0 Series chart Industry bar
Ulu Ventures 0 0 Series chart Industry bar